_id

691098b6ccc777a4e85d5c34

Ticker

ESLAW

Name

Estrella Immunopharma Inc.

Exchange

NASDAQ

Address

5858 Horton Street, EmeryVille, CA, United States, 94608

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.estrellabio.com

Description

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Last Close

0.0523

Volume

44000

Current Price

0.05

Change

-0.001

Last Updated

2026-01-03T11:10:34.008Z

Image

data:image/webp;base64,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

Ipo Date

2021-09-14T00:00:00.000Z

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

4801149

Operating Income

-4801149

Interest Expense

-

Pretax Income

-4801149

Net Income

-4801149

Eps

-0.12942489470030535

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

-

EBITDA

-4801149

Operating Margin

-

Total Other Income Expense Net

-

Cash

1626610

Short Term Investments

-

Receivables

396901

Inventories

-

Total Current Assets

2023511

Property Plant Equipment

-

Total Assets

3523511

Payables

5631

Short Term Debt

4000

Long Term Debt

-

Total Liabilities

13359934

Equity

-9836423

Bs_currency_symbol

USD

Depreciation

-

Change In Working Capital

3854357

Cash From Operations

-727332

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

1037348

Net Change In Cash

310016

Cf_currency_symbol

USD

PE

-

PB

-0.18856460320992705

ROE

48.809907829299334

ROA

-136.26036643563765

FCF

-727332

Fcf Percent

-

Piotroski FScore

1

Health Score

39

Deep Value Investing Score

0.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.8

Garp Investing Score

2

Growth Investing Score

2

Momentum Investing Score

5

Net Net Investing Score

0

Quality Investing Score

3

Value Investing Score

3

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

4801149

Quarters > 0 > income Statement > operating Income

-4801149

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-4801149

Quarters > 0 > income Statement > net Income

-4801149

Quarters > 0 > income Statement > eps

-0.12942489470030535

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

37096024

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-4801149

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-

Quarters > 0 > income Statement > currency_symbol

USD

Quarters > 0 > balance Sheet > cash

1626610

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

396901

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

2023511

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

3523511

Quarters > 0 > balance Sheet > payables

5631

Quarters > 0 > balance Sheet > short Term Debt

4000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

13359934

Quarters > 0 > balance Sheet > equity

-9836423

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-4801149

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

3854357

Quarters > 0 > cash Flow > cash From Operations

-727332

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

1037348

Quarters > 0 > cash Flow > net Change In Cash

310016

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-0.12942489470030535

Quarters > 0 > ratios > PB

-0.18856460320992705

Quarters > 0 > ratios > ROE

48.809907829299334

Quarters > 0 > ratios > ROA

-136.26036643563765

Quarters > 0 > ratios > FCF

-727332

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

39

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

5544028

Quarters > 1 > income Statement > operating Income

-5544028

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-5544028

Quarters > 1 > income Statement > net Income

-5544878

Quarters > 1 > income Statement > eps

-0.1533191675656105

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

36165589

Quarters > 1 > income Statement > income Tax Expense

850

Quarters > 1 > income Statement > EBITDA

-5544028

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-

Quarters > 1 > income Statement > currency_symbol

USD

Quarters > 1 > balance Sheet > cash

1316594

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

163933

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

1480527

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

2980527

Quarters > 1 > balance Sheet > payables

8154

Quarters > 1 > balance Sheet > short Term Debt

4000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

9075195

Quarters > 1 > balance Sheet > equity

-6094668

Quarters > 1 > balance Sheet > currency_symbol

USD

Quarters > 1 > cash Flow > net Income

-5544878

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

4970901

Quarters > 1 > cash Flow > cash From Operations

-414879

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

1310000

Quarters > 1 > cash Flow > net Change In Cash

895121

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.1533191675656105

Quarters > 1 > ratios > PB

-0.2966985978563558

Quarters > 1 > ratios > ROE

90.97916408244059

Quarters > 1 > ratios > ROA

-186.03683174150075

Quarters > 1 > ratios > FCF

-414879

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

39

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

2104298

Quarters > 2 > income Statement > operating Income

-2104298

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-2104298

Quarters > 2 > income Statement > net Income

-2104311

Quarters > 2 > income Statement > eps

-0.05814894336132406

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

36188293

Quarters > 2 > income Statement > income Tax Expense

13

Quarters > 2 > income Statement > EBITDA

-2104298

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-

Quarters > 2 > income Statement > currency_symbol

USD

Quarters > 2 > balance Sheet > cash

421473

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

944268

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

2444268

Quarters > 2 > balance Sheet > payables

13988

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

4275215

Quarters > 2 > balance Sheet > equity

-1830947

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

-2104311

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

1479235

Quarters > 2 > cash Flow > cash From Operations

-465981

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

-29462

Quarters > 2 > cash Flow > net Change In Cash

-495443

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.05814894336132406

Quarters > 2 > ratios > PB

-0.9882397742807411

Quarters > 2 > ratios > ROE

114.93019732411697

Quarters > 2 > ratios > ROA

-86.09166425285608

Quarters > 2 > ratios > FCF

-465981

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

-

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

1050227

Quarters > 3 > income Statement > operating Income

-1050227

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-1050227

Quarters > 3 > income Statement > net Income

-1050290

Quarters > 3 > income Statement > eps

-0.02863318127405375

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

36680870

Quarters > 3 > income Statement > income Tax Expense

63

Quarters > 3 > income Statement > EBITDA

-1050227

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

-

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

916916

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

1640777

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

3140777

Quarters > 3 > balance Sheet > payables

-

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

2997046

Quarters > 3 > balance Sheet > equity

143731

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

-1050290

Quarters > 3 > cash Flow > depreciation

-

Quarters > 3 > cash Flow > change In Working Capital

-278032

Quarters > 3 > cash Flow > cash From Operations

-896066

Quarters > 3 > cash Flow > capital Expenditures

4

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

15479

Quarters > 3 > cash Flow > net Change In Cash

-880587

Quarters > 3 > cash Flow > currency_symbol

-

Quarters > 3 > ratios > PE

-0.02863318127405375

Quarters > 3 > ratios > PB

12.760250050441451

Quarters > 3 > ratios > ROE

-730.7331055930871

Quarters > 3 > ratios > ROA

-33.440451200451356

Quarters > 3 > ratios > FCF

-896070

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

17

Annuals > 0 > quarter

2025-06-30

Annuals > 0 > income Statement > revenue

-

Annuals > 0 > income Statement > cost Of Revenue

-

Annuals > 0 > income Statement > gross Profit

-

Annuals > 0 > income Statement > operating Expenses

8845941

Annuals > 0 > income Statement > operating Income

-8845941

Annuals > 0 > income Statement > interest Expense

-

Annuals > 0 > income Statement > pretax Income

-8845941

Annuals > 0 > income Statement > net Income

-8847629

Annuals > 0 > income Statement > eps

-0.24120553847277887

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

36680870

Annuals > 0 > income Statement > income Tax Expense

1688

Annuals > 0 > income Statement > EBITDA

-8845941

Annuals > 0 > income Statement > operating Margin

-

Annuals > 0 > income Statement > total Other Income Expense Net

-

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

916916

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

-

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

1640777

Annuals > 0 > balance Sheet > property Plant Equipment

-

Annuals > 0 > balance Sheet > total Assets

3140777

Annuals > 0 > balance Sheet > payables

-

Annuals > 0 > balance Sheet > short Term Debt

-

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

2997046

Annuals > 0 > balance Sheet > equity

143731

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

-8847629

Annuals > 0 > cash Flow > depreciation

-39586

Annuals > 0 > cash Flow > change In Working Capital

775700

Annuals > 0 > cash Flow > cash From Operations

-7639673

Annuals > 0 > cash Flow > capital Expenditures

1

Annuals > 0 > cash Flow > cash From Investing

-

Annuals > 0 > cash Flow > cash From Financing

-489426

Annuals > 0 > cash Flow > net Change In Cash

-8129099

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

-0.24120553847277887

Annuals > 0 > ratios > PB

12.760250050441451

Annuals > 0 > ratios > ROE

-6155.685968928067

Annuals > 0 > ratios > ROA

-281.7019164366015

Annuals > 0 > ratios > FCF

-7639674

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-

Annuals > 0 > health Score

16

Annuals > 1 > quarter

2024-06-30

Annuals > 1 > income Statement > revenue

0

Annuals > 1 > income Statement > cost Of Revenue

-

Annuals > 1 > income Statement > gross Profit

-

Annuals > 1 > income Statement > operating Expenses

7310098

Annuals > 1 > income Statement > operating Income

-7310098

Annuals > 1 > income Statement > interest Expense

-

Annuals > 1 > income Statement > pretax Income

-7310098

Annuals > 1 > income Statement > net Income

-7311723

Annuals > 1 > income Statement > eps

-0.20771213348441894

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

35201232

Annuals > 1 > income Statement > income Tax Expense

1625

Annuals > 1 > income Statement > EBITDA

-7310098

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

-

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

4165428

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

288761

Annuals > 1 > balance Sheet > inventories

-288761

Annuals > 1 > balance Sheet > total Current Assets

4454189

Annuals > 1 > balance Sheet > property Plant Equipment

-

Annuals > 1 > balance Sheet > total Assets

4454189

Annuals > 1 > balance Sheet > payables

0

Annuals > 1 > balance Sheet > short Term Debt

-

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

180701

Annuals > 1 > balance Sheet > equity

4273488

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-7311723

Annuals > 1 > cash Flow > depreciation

-

Annuals > 1 > cash Flow > change In Working Capital

-9951236

Annuals > 1 > cash Flow > cash From Operations

-16068306

Annuals > 1 > cash Flow > capital Expenditures

4

Annuals > 1 > cash Flow > cash From Investing

4960647

Annuals > 1 > cash Flow > cash From Financing

12793941

Annuals > 1 > cash Flow > net Change In Cash

1686282

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-0.20771213348441894

Annuals > 1 > ratios > PB

0.41185598274758234

Annuals > 1 > ratios > ROE

-171.09496972964473

Annuals > 1 > ratios > ROA

-164.1538560667273

Annuals > 1 > ratios > FCF

-16068310

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

33

Annuals > 2 > quarter

2023-06-30

Annuals > 2 > income Statement > revenue

0

Annuals > 2 > income Statement > cost Of Revenue

-

Annuals > 2 > income Statement > gross Profit

-

Annuals > 2 > income Statement > operating Expenses

1569529

Annuals > 2 > income Statement > operating Income

-1569530

Annuals > 2 > income Statement > interest Expense

-

Annuals > 2 > income Statement > pretax Income

-915456

Annuals > 2 > income Statement > net Income

-996104

Annuals > 2 > income Statement > eps

-0.17284736828314717

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

5762911

Annuals > 2 > income Statement > income Tax Expense

80648

Annuals > 2 > income Statement > EBITDA

-686971

Annuals > 2 > income Statement > operating Margin

-

Annuals > 2 > income Statement > total Other Income Expense Net

654074

Annuals > 2 > income Statement > currency_symbol

USD

Annuals > 2 > balance Sheet > cash

40802

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

-

Annuals > 2 > balance Sheet > inventories

-

Annuals > 2 > balance Sheet > total Current Assets

52427

Annuals > 2 > balance Sheet > property Plant Equipment

-

Annuals > 2 > balance Sheet > total Assets

9986484

Annuals > 2 > balance Sheet > payables

46879

Annuals > 2 > balance Sheet > short Term Debt

498600

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

2915723

Annuals > 2 > balance Sheet > equity

7070761

Annuals > 2 > balance Sheet > currency_symbol

USD

Annuals > 2 > cash Flow > net Income

-996104

Annuals > 2 > cash Flow > depreciation

228485

Annuals > 2 > cash Flow > change In Working Capital

576855

Annuals > 2 > cash Flow > cash From Operations

-1043848

Annuals > 2 > cash Flow > capital Expenditures

0

Annuals > 2 > cash Flow > cash From Investing

36170124

Annuals > 2 > cash Flow > cash From Financing

-35564343

Annuals > 2 > cash Flow > net Change In Cash

-438066

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-0.17284736828314717

Annuals > 2 > ratios > PB

0.040751702680941984

Annuals > 2 > ratios > ROE

-14.08764912291619

Annuals > 2 > ratios > ROA

-9.974521563345016

Annuals > 2 > ratios > FCF

-1043848

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-

Annuals > 2 > health Score

33

Annuals > 3 > quarter

2022-06-30

Annuals > 3 > income Statement > revenue

0

Annuals > 3 > income Statement > cost Of Revenue

-

Annuals > 3 > income Statement > gross Profit

-

Annuals > 3 > income Statement > operating Expenses

1685347

Annuals > 3 > income Statement > operating Income

-1685347

Annuals > 3 > income Statement > interest Expense

-

Annuals > 3 > income Statement > pretax Income

-1685347

Annuals > 3 > income Statement > net Income

-1685347

Annuals > 3 > income Statement > eps

-0.28810827905704567

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

5849700

Annuals > 3 > income Statement > income Tax Expense

-235136

Annuals > 3 > income Statement > EBITDA

-11160

Annuals > 3 > income Statement > operating Margin

-

Annuals > 3 > income Statement > total Other Income Expense Net

1437629

Annuals > 3 > income Statement > currency_symbol

USD

Annuals > 3 > balance Sheet > cash

4088333

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

-

Annuals > 3 > balance Sheet > inventories

-

Annuals > 3 > balance Sheet > total Current Assets

4921666

Annuals > 3 > balance Sheet > property Plant Equipment

-

Annuals > 3 > balance Sheet > total Assets

4921666

Annuals > 3 > balance Sheet > payables

945587

Annuals > 3 > balance Sheet > short Term Debt

-

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

5961509

Annuals > 3 > balance Sheet > equity

-1039843

Annuals > 3 > balance Sheet > currency_symbol

USD

Annuals > 3 > cash Flow > net Income

-1685347

Annuals > 3 > cash Flow > depreciation

236558

Annuals > 3 > cash Flow > change In Working Capital

113351

Annuals > 3 > cash Flow > cash From Operations

-1442028

Annuals > 3 > cash Flow > capital Expenditures

0

Annuals > 3 > cash Flow > cash From Investing

-45186000

Annuals > 3 > cash Flow > cash From Financing

5530361

Annuals > 3 > cash Flow > net Change In Cash

4088333

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-0.28810827905704567

Annuals > 3 > ratios > PB

-0.2812780390885932

Annuals > 3 > ratios > ROE

162.07706355671002

Annuals > 3 > ratios > ROA

-34.2434248890518

Annuals > 3 > ratios > FCF

-1442028

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-

Annuals > 3 > health Score

30

Valuation > metrics > PE

-0.12942489470030535

Valuation > metrics > PB

-0.18856460320992705

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

48.809907829299334

Profitability > metrics > ROA

-237.2682431674451

Profitability > final Score

55

Profitability > verdict

Weak

Risk > final Score

50

Risk > verdict

High

Liquidity > metrics > Current Ratio

210.10393520922023

Liquidity > metrics > Quick Ratio

210.10393520922023

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

20

Prev Profitabilities > 0

55

Prev Profitabilities > 1

55

Prev Profitabilities > 2

15

Prev Risks > 0

50

Prev Risks > 1

50

Prev Risks > 2

26

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

50

Updated At

2026-01-20T21:47:35.791Z